Molecular Formula | C34H49NO12 |
Molar Mass | 663.75 |
Density | 1.190±0.06 g/cm3 (20 ºC 760 Torr) |
Boling Point | 781.1±60.0 °C(Predicted) |
pKa | 4.28±0.10(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
Physical and Chemical Properties | Bioactive Fmoc-NH-PEG8-CH2CH2COOH is a degradable ADC linker used in antibody drug conjugate (ADC) synthesis. |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
Target
Cleavable
PEGs
in vitro studies
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
biological activity | Fmoc-NH-PEG8-CH2CH2COOH is a degradable ADC linker used for antibody drug conjugate (ADC) synthesis. |
target | Cleavable PEGs |
in vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |